Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New vasopressin V1A receptor antagonists disclosed by Roche

Nov. 29, 2011

Hanmi applies for E.U. orphan drug designation for LAPS-rhGH

Nov. 28, 2011

biOasis enters agreement with Shire Human Genetic Therapies

Nov. 28, 2011

Novel compounds for diabetes prepared by Chinese team

Nov. 28, 2011

Asahi Kasei Pharma launches Teribone in Japan

Nov. 25, 2011

Novel IBAT inhibitors disclosed by GlaxoSmithKline

Nov. 25, 2011

Mesoblast and FDA agree on adult stem cell trial in type 2 diabetes

Nov. 24, 2011

Takeda files NDA for fixed-dose tablet of alogliptin/metformin

Nov. 24, 2011

Takeda Pharmaceuticals reports novel acetyl-CoA carboxylase inhibitors

Nov. 24, 2011

New compounds for bone disorders prepared by Daiichi Sankyo

Nov. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...